intravenous immune globulin ( iv-igg ) is approved for use in substitution therapy of immunodeficiency syndromes and treatment of idiopathic thrombocytopenic purpura ( itp ) .
C0085297
intravenous immune globulin
C0398650
idiopathic thrombocytopenic